Keros Therapeutics, Inc. (KROS) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $338.02M | -45.1% |
| 2024 | $615.89M | +66.4% |
| 2023 | $370.02M | +20.6% |
| 2022 | $306.78M | +20.2% |
| 2021 | $255.25M | -5.3% |
| 2020 | $269.44M | +2359.5% |
| 2019 | $10.96M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $338.02M | -45.1% |
| 2024 | $615.89M | +66.4% |
| 2023 | $370.02M | +20.6% |
| 2022 | $306.78M | +20.2% |
| 2021 | $255.25M | -5.3% |
| 2020 | $269.44M | +2359.5% |
| 2019 | $10.96M | — |